Delivery Order SPE2DB20D1004-SPE2DB22FF5F1

Award Date 4/15/22
Potential Completion Date 4/18/22
Potential Value $1.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat diabetes. The award has a ceiling value of $5,613.20 and an ultimate completion date of September 1, 2022. The contract is a firm fixed-price arrangement with no...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under a Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract provides for the delivery of Trulicity 4.5 mg/0.5 ml pens, a specialty medication for diabetes management. The contract has a ceiling value of $1,741.68 and a completion date of December 19, 2023. This award is not designated as a set-aside...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract covers the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat diabetes. The award has a ceiling value of $8,182.60 and a completion date of July 19, 2024. Amerisourcebergen, as the prime contractor, is responsible for supplying this pharmaceutical product to support...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under a $999,999,999 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract covers the delivery of Trulicity 1.5 mg/0.5 ml pens, which are used to treat diabetes. The award has a ceiling value of $2,211 and a completion date of January 13, 2022. This contract is part of the DLA's efforts to provide essential pharmaceutical products...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $10,153.55. The contract is for the supply of Trulicity 1.5 mg/0.5 ml pens, which are used to treat diabetes. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, which is responsible for providing medical supplies to the U.S. military and other federal agencies. The contract has an ultimate completion date of October 24, 2023 and is a firm...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB22FL5L7) under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract provides Trulicity 3 mg/0.5 ml pen 0.5 ml, a specialty medication for diabetes management, to support military treatment facilities and veterans' healthcare programs. The award, with a ceiling value of $5,441.68 and a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. The contract covers the delivery of Trulicity 1.5 mg/0.5 ml pens, a specialty medication used for diabetes management. The Firm Fixed Price contract has a ceiling value of $2,869.19 and a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract covers the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used for diabetes management. The award has a ceiling value of $5,409.60 and was made without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,902.80, is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a prescription medication used to manage diabetes. The IDC with the DLA, worth up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,306.26 and covers the supply of Trulicity 3 mg/0.5 ml pen 0.5 ml, a prescription medication used to manage diabetes. The award has an ultimate completion date of May 14, 2024. This contract is part of a larger $999,999,999 IDC held by Cencora,...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB22FF5F1
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 2025. The contract covers the delivery of Trulicity 3 mg/0.5 ml pens, a specialty medication used for diabetes management. The award has a ceiling value of $1,081.92 and was made on April 15, 2022, with an ultimate completion date of April 18, 2022. The contract is a firm-fixed-price arrangement, with no set-aside designation, indicating open competition. As a major pharmaceutical distributor, Amerisourcebergen plays a critical role in supplying essential medical products, including specialty medications, brand-name and generic drugs, and medical supplies, to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 12:31 PM